Premium
Mimicking a p53‐MDM2 interaction based on a stable immunoglobulin‐like domain scaffold
Author(s) -
JimenezSandoval Pedro,
MadrigalCarrillo Ezequiel A.,
SantamaríaSuárez Hugo A.,
Maturana Daniel,
RenteríaGonzález Itzel,
BenitezCardoza Claudia G.,
TorresLarios Alfredo,
Brieba Luis G.
Publication year - 2018
Publication title -
proteins: structure, function, and bioinformatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.699
H-Index - 191
eISSN - 1097-0134
pISSN - 0887-3585
DOI - 10.1002/prot.25519
Subject(s) - peptide , immunoglobulin domain , protein–protein interaction , peptide sequence , scaffold protein , protease , antibody , immunoglobulin fab fragments , protein structure , chemistry , cysteine protease , fusion protein , biology , cysteine , microbiology and biotechnology , biochemistry , receptor , recombinant dna , enzyme , signal transduction , genetics , complementarity determining region , gene
Antibodies recognize protein targets with great affinity and specificity. However, posttranslational modifications and the presence of intrinsic disulfide‐bonds pose difficulties for their industrial use. The immunoglobulin fold is one of the most ubiquitous folds in nature and it is found in many proteins besides antibodies. An example of a protein family with an immunoglobulin‐like fold is the Cysteine Protease Inhibitors (ICP) family I42 of the MEROPs database for protease and protease inhibitors. Members of this protein family are thermostable and do not present internal disulfide bonds. Crystal structures of several ICPs indicate that they resemble the Ig‐like domain of the human T cell co‐receptor CD8α As ICPs present 2 flexible recognition loops that vary accordingly to their targeted protease, we hypothesize that members of this protein family would be ideal to design peptide aptamers that mimic protein‐protein interactions. Herein, we use an ICP variant from Entamoeba histolytica (EhICP1) to mimic the interaction between p53 and MDM2. We found that a 13 amino‐acid peptide derived from p53 can be introduced in 2 variable loops (DE, FG) but not the third (BC). Chimeric EhICP1‐p53 form a stable complex with MDM2 at a micromolar range. Crystal structure of the EhICP1‐p53(FG)‐loop variant in complex with MDM2 reveals a swapping subdomain between 2 chimeric molecules, however, the p53 peptide interacts with MDM2 as in previous crystal structures. The structural details of the EhICP1‐p53(FG) interaction with MDM2 resemble the interaction between an antibody and MDM2.